InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,995.54
(
0.38%
)
US TECH 100
20,562.00
(
0.10%
)
Dow Jones
43,988.99
(
0.59%
)
Brent Oil
73.89
(
0.00%
)
Bitcoin
76,331.61
(
-0.31%
)
Post# of 2804248
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

pullbackbaby

Send PM Follow Ignore
Followers 0
Posts 44
Boards Moderated 0
Alias Born 01/23/2010

pullbackbaby

Re: None

Monday, 11/22/2010 1:02:02 AM

Monday, November 22, 2010 1:02:02 AM

Post# of 2804248
ACTC news out.. It is on Etrade .. Chart is sweet too.

WASHINGTON (AFP)--Human embryonic stem cells were set to be tested as a treatment for blindness, a U.S. company announced Monday in the
second such clinical trial to examine how the controversial process works in people. Just 12 adult patients were set to take part in the trial to determine how the
treatment using retinal cells, derived from human embryonic stem cells, affects patients with a common form of vision loss that takes hold in children as young as six. The
process has been tested on rats and mice, and has been found to halt the progressive disease without causing tumors or other side effects, said chief scientific officer
Bob Lanza at the biotech company Advanced Cell Technology Inc. (ACTC).
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up